Navigation Links
Millions of Euros could be saved if breast cancer follow-ups were led by specialist nurses
Date:4/18/2008

Berlin, Germany: Follow-up care for breast cancer patients costs less if it is conducted by nurses rather than physicians, yet there is no difference in the patients anxiety, depression, satisfaction or outcome, according to research presented today (Friday) at the 6th European Breast Cancer Conference (EBCC-6) in Berlin.

The study found that over a five-year period the cost of follow-up care was 630 per person per year for patients who saw a physician and 495 per person per year for those who saw specialist cancer nurses. Over a five-year period this made a difference of 866 per patient a modest saving per patient, but one that would enable substantial savings to be made in a countrys health budget as breast cancer is the most prevalent tumour worldwide.

Dr IngaLill Koinberg, who is both a nurse and medical doctor at the Department of Research and Development, Hospital Varberg and Kristianstad University, Sweden, said: These results showed that follow-up led by specialist nurses, with check-ups on demand, were 20% less expensive than routine follow-up visits to the physician. The main difference in cost between physician-led follow-up and nurse-led follow-up was explained by the number of visits to the physician. There were 21% more contacts with the physician in the physician group than in the nurse group.

Dr Koinberg and her colleagues randomised 264 breast cancer patients to two different follow-up groups in a prospective trial. Women in the physician group had routine medical follow-ups by a physician, involving four visits per year in the first two years, then examinations twice a year for up to five years, and annually thereafter. In the nurse group, patients saw a specialist nurse three months after the initial visit to the physician following radiotherapy. They were told how to recognise recurrence in the breast, skin, axillary nodes and scar tissue, and to telephone the nurse if they had any questions or symptoms of cancer
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Better Hearing Institute Kicks Off the Across America Hearing Check Challenge for Better Hearing and Speech Month, Bringing Better Quality of Life Back to Millions of Americans
2. Research could put penicillin back in battle against antibiotic resistant bugs that kill millions
3. Enhanced U.S. Efforts to Fight Tropical Disease Offer Hope to Millions of Patients
4. Asthma Foundation Expands Certification Program to be Friendly to Millions More
5. ABA Conference in Chicago Provides Litigators First Look at DNA Technology That Can Save Millions in Workers Comp and Toxic Tort Cases
6. 32nd Annual Hutch Holiday Gala Raises Millions for Cancer Research
7. Mitts Millions Cant Buy Iowans Health Care Reform
8. Thanks to Homecare, Millions of Older Americans Celebrate Thanksgiving and Other Holidays at Home
9. Report Shows Millions May Be Driving with Uncorrected Visual Impairments
10. TransMedia Group to Open Curtain on Innovative Hospital Bed Curtain that Will Save Millions in Maintenance
11. Saving Millions of Childrens Lives Is Possible
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...Susan Butcher the famous iditarod champion was det...rticipate in the 300-mile sled dog race conducted ...of the 1100-mile Iditarod Trail Sled Dog Race. She...ce of survival with the same grit and confidence. ...
...There appears to be a remarkable laxity among the ...ng skin cancer. Felipe Beltran, the spokesman for ... has admitted that the organization’s drive agains...ed impact. The online study of the QIMR did not e...
...Researchers from Germany have discovered a novel, ...of coronary veins. This technique, called ECG-gate...DCT, is associated with very few complications // ... improved diagnostic quality and treatment. A com...
...A research was conducted by Selda Samakoglu and co...nter. This research opened new doors in the treatm.... The treatment combines both gene therapy and RNA...eatment has worked well in the laboratory stage an...
Other Medicine News:Health News:Treatment of Sickle Cell Anemia Using Gene Therapy. 2
(Date:10/6/2008)...E Therapy is More Likely to Induce Steroid-Free ...rd Immunomodulator, Azathiopri...esented for the first time,from the Phase 3b Study...odulators and Biologic Therapy (SONIC) may provide...s with moderate to severe Crohn,s disease.,Accordi...
(Date:10/6/2008)...Oct. 6 /- Complete,Genomics Inc., a n...ncing,company, and the Institute for Systems Biolo...uct populationwide human genome studies., In phas...ts proprietary,DNA sequencing technology to sequen..., once proof-of-concept has been demonstrated, ISB...
(Date:10/6/2008)...d for 9:00 AM ET Today -, SEATTLE, Oct. 6 /PRNews...NDN) announced today that it has completed the pla...double-blind, placebo-controlled IMPACT,(IMmunothe...nown as D9902B),clinical trial designed to assess ...ive cellular immunotherapy PROVENGE(R) (sipuleucel...
(Date:10/6/2008)...6 Weeks of Radiation Therapy -, Event: Watch Singl...sday, October 22, 2008, 3 - 4 p.m. by visiting ...Va., Oct. 6 / Questions raced through...st cancer in May. Would she have the,tumor removed...otherapy?, , To view the Multimedia News Release...
Breaking Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections 4037 1FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections 4037 2Pharmacopeia to Receive 245 Million Payment from GlaxoSmithKline 4034 1Pharmacopeia to Receive 245 Million Payment from GlaxoSmithKline 4034 2Pharmacopeia to Receive 245 Million Payment from GlaxoSmithKline 4034 3Pharmacopeia to Receive 245 Million Payment from GlaxoSmithKline 4034 4DiObex and Camurus Sign License Agreement for the Development of DIO 901 in FluidCrystal 28R 29 Extended Release Technology 4031 1DiObex and Camurus Sign License Agreement for the Development of DIO 901 in FluidCrystal 28R 29 Extended Release Technology 4031 2TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 1TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 2
...wswire/ -- D-Pharm announced,today that the result...ompound DP-b99 in the treatment of acute ischemic,...Stroke,Conference. The data will be presented by t...C. Diener, on Thursday May 31st at,14.30 in the Ca...enter in Glasgow. The abstract for the presentatio...
... and on three investigational,agents (VEGF Trap, S...nual ASCO meeting, BRIDGEWATER, N.J., May 29, 2007...d today that a total of 375 abstracts,indicative o...he,43rd Annual Meeting of the American Society of ...e 1-5, 2007). The results from key,studies involvi...
Other Medicine Technology:DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 2DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 2Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 5Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 6Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 7Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 8Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 9Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 10Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 11Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 12
...ing: The Procleix System has added a significant ... utilizes innovative technologies developed by Gen...eic acid amplification technique called Transcript...V-1/HCV Assay can simultaneously detect the presen...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca
...assay: Uni-Gold Recombigen HIV is a single use rap...in plasma, serum and whole blood (venipuncture). U...t of care settings as an aid in diagnosis of infec...appropriate multi-test algorithms designed for the...
The advanced performance benefits of TiMAX material have been applied to the ACE Pe.R.I. (Periarticular Reduction Implants) Upper Extremity Plates. Greater strength, less rigidity combine to provide
Medicine Products: